Roche Holding AG
RO | SW
Overview
Corporate Details
- ISIN(s):
- CH0012032048 (+1 more)
- LEI:
- 549300U41AUUVOAAOB37
- Country:
- Switzerland
- Address:
- Grenzacherstr. 124, 4058 Basel
- Website:
- https://www.roche.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world, and the leading provider of cancer treatments globally. Together, a potent new drug and a blood test to guide its use can be a life changer for patients. We are a global leader in both sectors: the world’s biggest biopharmaceuticals company, the leading supplier of in vitro diagnostics and an innovator across major disease areas.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2004-12-31 00:00 |
Annual Report
Annual Report 2004
|
English | 8.5 MB | |
| 2004-12-31 00:00 |
Annual Report
Jahresbericht 2004
|
German | 8.8 MB | |
| 2004-04-22 00:00 |
Investor Presentation
Presentation to analysts
First Quarter 2004
Basle, April 21, 2004
|
English | 1.2 MB | |
| 2003-12-31 00:00 |
Annual Report
Annual Report 2003
|
English | 8.4 MB | |
| 2003-12-31 00:00 |
Annual Report
Jahresbericht 2003
|
German | 8.5 MB | |
| 2003-07-25 00:00 |
Investor Presentation
First Half 2003
Presentation to analysts
|
English | 1.1 MB | |
| 2003-04-11 00:00 |
Investor Presentation
26 March 2003Roadshow USANew York
|
English | 175.9 KB | |
| 2003-04-10 00:00 |
Investor Presentation
Company Presentation 2003
|
English | 250.3 KB | |
| 2003-02-12 00:00 |
Investor Presentation
16 January 2003 Roadshow Germany
|
English | 323.7 KB | |
| 2002-12-31 00:00 |
Annual Report
Annual Report 2002
|
English | 9.3 MB | |
| 2002-12-31 00:00 |
Annual Report
Jahresbericht 2002
|
German | 9.7 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-16 | N/A | Executive member | Sell | None | 1,494,248.20 CHF |
| 2025-02-07 | N/A | Non-Executive member | Buy | None | 613,652.00 CHF |
| 2024-07-26 | N/A | Non-Executive member | Sell | None | 1,743,760.00 CHF |
| 2024-07-25 | N/A | Non-Executive member | Sell | None | 723,460.00 CHF |
| 2024-06-21 | N/A | Executive member | Sell | None | 2,220,432.00 CHF |
| 2024-06-10 | N/A | Executive member | Sell | None | 1,260,138.00 CHF |
| 2024-05-29 | N/A | Non-Executive member | Buy | None | 504,400.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
KANABO GROUP PLC | United Kingdom | KNB | |
|
Karo Pharma AB | Sweden | KARO | |
|
Kinarus Therapeutics Holding AG | Switzerland | KNRS | |
|
Klaria Pharma Holding AB | Sweden | KLAR | |
|
Kolinpharma | Italy | KIP | |
|
Krka | Slovenia | KRKG | |
|
Kyivmedpreparat | Ukraine | KMED | |
|
Labiana S.A. | Spain | LAB | |
|
Labocanna Spolka Akcyjna | Poland | LCN | |
|
Laboratorio Farmaceutico Erfo | Italy | ERFO |